Application of the Original L-Ornithine-L-Aspartate in Patients with Complex Cardiovascular Disease and Type 2 Diabetes Mellitus

Application of the Original L-Ornithine-L-Aspartate in Patients with Complex Cardiovascular Disease and Type 2 Diabetes Mellitus

The article deals with the treatment of nonalcoholic fatty liver disease as a complication in patients with complex cardiovascular disease and type 2 diabetes mellitus. The data from the studies on the effect of Hepa-Merz® on the functional state of the liver, endothelium, blood rheology, the state...

Full description

Bibliographic Details
Main Authors: V.Yu. Zharynova, K.N. Ihrunova, L.A. Bodretska, V.P. Chyzhova, I.A. Samots, Zh.S. Butynets, A.Yu. Haletskyi, N.N. Benkovska, V.O. Tabakovych-Vatseba
Format: Article
Language:English
Published: Zaslavsky O.Yu. 2015-11-01
Series:Mìžnarodnij Endokrinologìčnij Žurnal
Subjects:
diabetes mellitus
cardiovascular disease
hepatoprotectors
non-alcoholic fatty liver disease
Online Access:http://iej.zaslavsky.com.ua/article/view/72335
Description
Summary:The article deals with the treatment of nonalcoholic fatty liver disease as a complication in patients with complex cardiovascular disease and type 2 diabetes mellitus. The data from the studies on the effect of Hepa-Merz® on the functional state of the liver, endothelium, blood rheology, the state of the capillary circulation, endotoxemia markers and clinical status in these patients are presented. The findings confirm the possibility of the influence of Hepa-Merz® on the functional disorders of the liver in patients with complex cardiovascular disease and type 2 diabetes mellitus.
ISSN:2224-0721
2307-1427

Similar Items